Clinical use of tranexamic acid: evidences and controversies

Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical procedures and improves survival rates in obstetric and trauma patients with severe bleeding. Although it mainly acts as a fibrinolysis inhibitor, it also has an anti-inflammatory effect, and may help attenuate the sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Colomina, Maria J., Contreras, Laura, Guilabert, Patricia, Koo, Maylin, M..ndez, Esther, Sabate, Antoni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660007/
https://www.ncbi.nlm.nih.gov/pubmed/34626756
http://dx.doi.org/10.1016/j.bjane.2021.08.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660007/
https://www.ncbi.nlm.nih.gov/pubmed/34626756
http://dx.doi.org/10.1016/j.bjane.2021.08.022

Ejemplares similares